FDA Inspection 650762 — Janzen, Mark A. Ph.D., Clinical Investigator

Janzen, Mark A. Ph.D., Clinical Investigator — FEI 3008228448

The FDA completed an inspection of Janzen, Mark A. Ph.D., Clinical Investigator on Mar 9, 2010 in Saint Paul, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 9, 2010
Fiscal Year
2010
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Saint Paul, MN (United States)

Additional Details

Clinical Investigator (CI)